AKBA
Akebia Therapeutics Inc.
-38.05%
$1.13 - $0.70
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
Good FDA news -- stock is up!
Mar, 17, 2023
we can hear about FDAs decision anyday starting Th... See more
Mar, 21, 2023
Good FDA news -- stock is up!
Mar, 17, 2023
we can hear about FDAs decision anyday starting Thursday..exciting times ahead
Mar, 10, 2023
but a positive for the FDA as Dr. Stein looks at the label.
Feb, 26, 2023
*******” another BIG reason why the FDA should approve it!!! !
Feb, 25, 2023
Home run with FDA, path forward soon.
Feb, 24, 2023
And some are saying oh its just an opinion, this is actually fantastic news for us and will open the door to other countries for approval and HOPEFULLY the US fda will approve it.
Feb, 24, 2023
$AKBA We should be very happy at current recovery, Im holding the rest of my position right into partner, FDA the lot Yesterdays news was amazing
Feb, 24, 2023
It is clean for the FDA.
Feb, 24, 2023
This bodes very well for fda FDRR approval.
Feb, 24, 2023
$AKBA FDA, please listen and read: “The benefit of Vafseo is its ability to correct haemoglobin levels in dialysis-dependent patients, with effects comparable to those seen with erythropoiesis-stimulating agents.